Introduction:
The Z-drug zolpidem is an imidazopyridine hypnotic that is prescribed widely for short-term treatment of sleeping problems. However, there have been various cases affected by the side effects of this medication.
IJ Psychiatry and Behavioral Sciences
IJPBS is the Official Journal of Mazandaran University of Medical Sciences
Image Credit:Iran J Psychiatry Behav Sci
Authors
The Z-drug zolpidem is an imidazopyridine hypnotic that is prescribed widely for short-term treatment of sleeping problems. However, there have been various cases affected by the side effects of this medication.
Further to the extant reports of zolpidem adverse reactions, in the current manuscript, two cases of zolpidem toxicity in 2016 in Tehran are presented. They had both taken 20 mg of zolpidem and as a result, they began to develop an altered level of mentality.
Zolpidem use may affect the mental status and results in performing unconscious behaviors.
Authors' Contribution:Abdolhamid Parsa performed the critical revision of the manuscript for important intellectual content. Mohammad Babaeian collected and interpreted the clinical data, study concept, and design and prepared the manuscript.
Declaration of Interest:All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers' bureaus, membership, employment, consultancies, stock ownership, or other equity interest, and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.
Funding/Support:No funding was received for this research.
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Babaeian M, Ayazkhoo L. Re-evaluating the Safety of Zolpidem: Risks and Clinical Implications. Iran J Pharm Res. 2025;24(1):e164946. doi: https://doi.org/10.5812/ijpr-164946
Faridhosseini F, Zamani A. A Case Report of Somnambulism AssociatedWith Olanzapine. Iran J Psychiatry Behav Sci. 2012;6(1):. doi:
Derakhshan P, Faiz SHR, Emami A, Mohseni M, Shirani M. A Double-Blind Clinical Trial to Determine the Effect of Oral Zolpidem and Midazolam on the Level of Preoperative Anxiety in Children Undergoing Eye Examination Under General Anesthesia. Inn J Pediatr. 2020;30(3):e102183. doi: https://doi.org/10.5812/ijp.102183
Saeidi M, Alikhani R, Hormati A, Sabouri SM, Aminnejad R. Propofol-Induced Masseter Muscle Spasm in a Woman with a Major Depressive Disorder. Anesth Pain Med. 2018;8(3):e78748. doi: https://doi.org/10.5812/aapm.78748
Eizadi-Mood N, Sabzghabaee AM, Gheshlaghi F, Yaraghi A. Amitraz Poisoning Treatment: Still Supportive?. Iran J Pharm Res. 2011;10(1):e125913. doi: https://doi.org/10.22037/ijpr.2010.875
Last Update: 5 days ago
Last Update: 5 days ago
Last Update: 5 days ago
Last Update: 6 days ago
Last Update: 2 days ago
Last Update: 3 days ago